Moreover, they showed that through inhibiting TXNIP expression, verapamil treatment significantly reduced β-cell apoptosis, promoted β-cell survival and glucose homeostasis, prevented diabetes progression or delayed diabetes development, and could even avert diabetes in streptozotocin-treated mice (Xu et al., 2012). Here, TXNIP is linked to diabetes mellitus.